Eptifibatide

From WikiAnesthesia
Revision as of 01:11, 30 March 2022 by Chris Rishel (talk | contribs) (Created page with "{{Infobox drug reference | trade_names = Integrilin | drug_class = | drug_class_color = | uses = | contraindications = | routes = | dosage = |dosage_calculation=eptifibatide}} Provide a brief summary of this drug here. ==Uses<!-- Describe uses of the drug. If appropriate, add subsections for each indication. -->== ==Contraindications<!-- List contraindications and precautions for use of the drug. -->== ===Absolute contraindications<!-- List absolute contraindic...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Eptifibatide
Trade names

Integrilin

Clinical data
Dosage
Load
  • 180 mcg/kg IV
Maintenance
  • 2 mcg/kg IV
Indication 
Acute coronary syndrome
Route 
Intravenous

Infusion should be continued until discharge or up to 18-24 hr after procedure (whichever comes first), providing up to 96 hr of therapy.

Pharmacodynamics
Pharmacokinetics
Physical and chemical data
Article quality
Editor rating
Unrated
User likes
0

Provide a brief summary of this drug here.

Uses

Contraindications

Absolute contraindications

Precautions

Pharmacology

Pharmacodynamics

Mechanism of action

Adverse effects

Pharmacokinetics

Chemistry and formulation

History

References